No Data
Three key points to watch in the morning session - considering the results of the US CPI and major US bank earnings.
In the trading session 16 days ago, there are three key points to focus on: ■ The results of the US CPI and major US bank earnings as materials ■ Okumura Group's 2Q operating profit decreased by 87.7%, totaling 0.791 billion yen ■ Attention materials from the morning session: Mitsubishi Electric Corp. Unsponsored ADR promoted research and development expenses of 100 billion yen, collaborating broadly both domestically and internationally. The Japanese stock market on the 16th seems poised for a buy-strong environment. In the US market on the 15th, the Dow Jones Industrial Average rose by 703 points, and the Nasdaq increased by 466 points. 2024.
Mitsubishi Electric Corp. Unsponsored ADR, Asahi Kasei ETC [List of stock materials from the newspaper]
* Mitsubishi Electric Corp. Unsponsored ADR ＜6503＞ allocates 100 billion yen for collaborative research and development with universities, industries, and government, widely both domestically and internationally (Daily Industrial News, page 3) - ○ * KOSÉ Corp. ＜4922＞ invests in its Indian subsidiary, aiming for a new Cosmetic brand (Daily Industrial News, page 4) - ○ * Itochu Corporation ＜8001＞ invests in green hydrogen production in the UK (Daily Industrial News, page 4) - ○ * Yokogawa Electric Corporation ＜6841＞ launches a system for offshore wind power, continuously monitoring seabed cables (Daily Industrial News, page 9) - ○ * Konica Minolta ＜4902＞ detects deficiencies in protective gear using AI, targeting domestic and Asia markets (Daily Industrial News}
Kaneka rebounds after six days, reported the development of solar panels that do not produce waste from Components and materials.
Kaneka <4118.T> rebounded after six days, temporarily rising 52 yen to 3,708 yen. The October 10th edition of the Nihon Keizai Shimbun reported that the company plans to develop solar panels that will not generate waste from Components and materials after use by 2030, serving as a stimulating factor. According to the newspaper, the method of securing the main components of the solar panels will be improved to facilitate the reuse of rare Metals and reduce the Energy consumption from production to disposal by one-third.
Three key points to focus on before the session - funds are likely to target short-term price fluctuations in material stocks ETC.
In the trading session 10 days ago, I would like to focus on the following three points. ■ Funds aiming for short-term price fluctuations tend to be attracted to material stocks and the like. ■ Fast Retailing, 1Q operating profit increased by 7.4% to 157.5 billion yen. ■ Highlight materials from the morning session: Hitachi, utilizing Metaverse, is streamlining Sewerage maintenance and DC management. ■ Funds aiming for short-term price fluctuations tend to be attracted to material stocks and the like. The Japanese stock market on the 10th is likely to develop in a stagnant manner, with limited market participants. The US market on the 9th was influenced by former President Carter.
Hitachi, Symphonia, etc. [List of stock materials from the newspaper]
* Hitachi <6501> utilizes the Metaverse to streamline sewerage maintenance and data center management (Nikkan Kogyo, page 1) - ○ * Kaneka <4118> acquires an Israeli company, developing aneurysm treatment devices (Nikkan Kogyo, page 3) - ○ * Marubeni <8002> establishes a sales company for machinery in India, enhancing services and sales (Nikkan Kogyo, page 4) - ○ * Symphony <6507> autonomous transport for semiconductor panels, up to 600 mm square, for advanced back-end processes (Nikkan Kogyo, page 9) - ○ * Iseki Agriculture <6310> automates straight-line harvesting, reducing labor for large combines.
Kaneka has made ESM in Israel a subsidiary.
Kaneka <4118.T> announced on the 9th that it has acquired 96.8% of the stocks of the Israeli medical device company Endostream Medical (ESM) on December 23, 2024, making it a subsidiary. According to the company, ESM is a manufacturer with innovative technology in the field of cerebrovascular diseases. It is developing a cerebral aneurysm treatment device called 'Nautilus' that can treat aneurysms with a wide opening, which has been long awaited in the treatment field, aiming for a November 2024 launch in the European Index.
